Alps Advisors Inc Zoetis Inc. Transaction History

Alps Advisors Inc

$15.7 Billion
Q4 2024

A detailed history of Alps Advisors Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 24,004 shares of ZTS stock, worth $3.93 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,004

Previous 24,078 0.31%

Holding current value

$3.93 Million

Previous $4.7 Million 16.88%

% of portfolio

0.02%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$162.24 - $194.42 $12,005 - $14,387	-74 Reduced 0.31%	24,004 $3.91 Million
Q3 2024 Nov 12, 2024	BUY	$172.58 - $196.48 $895,690 - $1.02 Million	5,190 Added 27.48%	24,078 $4.7 Million
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $3,201 - $3,934	-22 Reduced 0.12%	18,888 $3.27 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $67,262 - $81,175	406 Added 2.19%	18,910 $3.2 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $2,120 - $2,801	-14 Reduced 0.08%	18,504 $3.65 Million
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $726,056 - $837,392	4,344 Added 30.65%	18,518 $3.22 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $190,874 - $220,868	1,186 Added 9.13%	14,174 $2.44 Million
Q1 2023 May 10, 2023	SELL	$145.48 - $175.02 $149,117 - $179,395	-1,025 Reduced 7.31%	12,988 $2.16 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $250,870 - $301,240	-1,913 Reduced 12.01%	14,013 $2.05 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $22,095 - $27,199	149 Added 0.94%	15,926 $2.36 Million
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $2.22 Million - $2.85 Million	14,246 Added 930.5%	15,777 $2.71 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $806,278 - $1.04 Million	-4,445 Reduced 74.38%	1,531 $289,000
Q4 2021 Feb 09, 2022	SELL	$193.69 - $247.03 $1.75 Million - $2.23 Million	-9,045 Reduced 60.22%	5,976 $1.46 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $122,470 - $135,669	-647 Reduced 4.13%	15,021 $2.92 Million
Q2 2021 Aug 11, 2021	BUY	$155.9 - $187.99 $2,650 - $3,195	17 Added 0.11%	15,668 $2.92 Million
Q1 2021 May 07, 2021	SELL	$144.0 - $169.39 $212,688 - $250,189	-1,477 Reduced 8.62%	15,651 $2.46 Million
Q4 2020 Feb 03, 2021	SELL	$157.07 - $174.35 $149,059 - $165,458	-949 Reduced 5.25%	17,128 $2.84 Million
Q3 2020 Nov 04, 2020	SELL	$137.1 - $165.37 $138,196 - $166,692	-1,008 Reduced 5.28%	18,077 $2.99 Million
Q2 2020 Aug 05, 2020	SELL	$111.92 - $142.53 $108,114 - $137,683	-966 Reduced 4.82%	19,085 $2.62 Million
Q1 2020 May 06, 2020	BUY	$92.66 - $144.94 $713,852 - $1.12 Million	7,704 Added 62.4%	20,051 $2.36 Million
Q4 2019 Feb 07, 2020	SELL	$116.25 - $133.25 $58,008 - $66,491	-499 Reduced 3.88%	12,347 $1.63 Million
Q3 2019 Nov 04, 2019	SELL	$112.57 - $128.43 $262,175 - $299,113	-2,329 Reduced 15.35%	12,846 $1.6 Million
Q2 2019 Aug 07, 2019	SELL	$97.98 - $114.28 $245,145 - $285,928	-2,502 Reduced 14.15%	15,175 $1.72 Million
Q1 2019 May 01, 2019	SELL	$81.56 - $100.67 $167,768 - $207,078	-2,057 Reduced 10.42%	17,677 $1.78 Million
Q4 2018 Feb 04, 2019	BUY	$79.28 - $95.27 $32,980 - $39,632	416 Added 2.15%	19,734 $1.69 Million
Q3 2018 Oct 25, 2018	BUY	$83.5 - $93.23 $1.16 Million - $1.3 Million	13,892 Added 256.03%	19,318 $1.77 Million
Q2 2018 Aug 02, 2018	SELL	$79.9 - $89.2 $141,183 - $157,616	-1,767 Reduced 24.57%	5,426 $462,000
Q2 2018 Jul 31, 2018	SELL	$79.9 - $89.2 $907,983 - $1.01 Million	-11,364 Reduced 61.24%	7,193 $518,000
Q2 2018 Jul 25, 2018	BUY	$79.9 - $89.2 $574,720 - $641,615	7,193 Added 63.3%	18,557 $1.47 Million
Q1 2018 May 01, 2018	BUY	$71.51 - $84.69 $298,268 - $353,241	4,171 Added 57.99%	11,364 $950,000
Q3 2017 Nov 03, 2017	BUY	$59.73 - $65.4 $429,637 - $470,422	7,193	7,193 $459,000

Others Institutions Holding ZTS

# of Institutions

2,062

Shares Held

420M

Call Options Held

1.22M

Put Options Held

1.61M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $76.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Zoetis Inc. Transaction History